Home » Topics » Regulatory

Regulatory
RSS

Muse approved in U.K.

Dec. 2, 1997

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

Teva receives FDA approval for generic etodolac

Dec. 1, 1997

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Immunex seeks FDA approval for generic paclitaxel injection

Nov. 28, 1997

First anticancer monoclonal antibody approved by FDA

Nov. 27, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

Forest files for FDA approval of Synapton

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...